Hybrid Antibiotics Based on Azithromycin and Glycopeptides: Synthesis and Antibacterial Activity
Abstract
A series of hybrid antibiotics on the basis of azithromycin and glycopeptides with the glycopeptide molecule attached via the aminoalkylcarbamoyl spacer to 11-position of the macrolide was synthesized. All the synthesized compounds demonstrated equal or superior to azithromycin and vancomycin antibacterial activity against 7 tested strains of grampositive bacteria. The new hybrid antibiotics were more active than azithromycin or vancomycin against S.pneumoniae ATCC 49619. Some of the compounds were active against E.faecium and E.faecalis strains resistant to vancomycin.
About the Authors
S. S. Printsevskaya
Научно-исследовательский институт по изысканию новых антибиотиков им. Г. Ф. Гаузе
Russian Federation
Russian Federation
A. M. Korolev
Научно-исследовательский институт по изысканию новых антибиотиков им. Г. Ф. Гаузе
Russian Federation
Russian Federation
E. B. Isakova
Научно-исследовательский институт по изысканию новых антибиотиков им. Г. Ф. Гаузе
Russian Federation
Russian Federation
E. P. Mirchink
Научно-исследовательский институт по изысканию новых антибиотиков им. Г. Ф. Гаузе
Russian Federation
Russian Federation
A. N. Tevyashova
Научно-исследовательский институт по изысканию новых антибиотиков им. Г. Ф. Гаузе; Российский университет дружбы народов
Russian Federation
Russian Federation
References
1. Тевяшова А.Н., Олсуфьева Е.Н., Преображенская М.Н. Создание антибиотиков двойного действия как путь поиска новых перспективных лекарственных препаратов. Успехи химии 2015; 84: 61-97. / Tevjashova A.N., Olsufeva E.N., Preobrazhenskaja M.N. Sozdanie antibiotikov dvojnogo dejstvija kak put' poiska novyh perspektivnyh lekarstvennyh preparatov. Uspehi himii 2015; 84: 61-97. [in Russian]
2. Butler M.S, Blaskovich M.A.T., Cooper M.A. Antibiotics in the clinical pipeline at the end of 2015. J Antibiot 2016; doi:10.1038/ja.2016.72.
3. Parnham M.J., Erakovic Haber V., Giamarellos-Bourboulis E.J., Perletti G., Verleden G.M., Vos R. Azithromycin: mechanisms of action and their relevance for clinical applications. Pharmacol Ther 2014; 143: 2: 225-245.
4. Lalak N.J., Morris D.L. Azithromycin clinical pharmacokinetics. Clinic Pharmacokinetics 1993; 25: 370-374.
5. Gladue R.P., Bright G.M., Isaacson R.E., Newborg M.F. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemoth 1990; 34: 1056-1060.
6. Deresinski S. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2009; 49: 1072-1079.
7. Martinez J.A., Horcajada J.P., Almela M., Marco F.,Soriano A., Garcia A., Marco M.A. et al. Addition ofa macrolide to a/З-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic Pneumococcal pneumonia. Clin Infect Dis 2003; 36: 389-395.
8. Sztaricskai F., Pelyvâs-Ferenczik I. Chemistry of carbohydrate components. In: Glycopeptide Antibiotics, 1st edn (Ed. Nagarajan R.), 1994, Marcel Dekker, New York, NY, USA.
9. Gause G.F., Brazhnikova M.G., Lomakina N.N., Berdnikova T.F., Fedorova G.B., Tokareva N.L. et al. Eremomycin - new glycopeptide antibiotics. Chemical properties and structure. J Antibiot 1989; 42: 1790-1799.
10. Reynolds P.E. Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis 1989; 8: 11: 943-950.
11. Niu D. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, Sept 27-30, 2002, Abst F 1666.
12. Ma S., Jiao B., Liu Z., Wang H., Xian R., Zheng M., Lou H. Synthesis and antibacterial activity of 4”,11-di-O-arylalkylcarbamoyl-azithromycin derivatives. Bioorg Med Chem Lett 2009; 19: 1698-1701.
13. Li X., Ma S., Yan M., Wang Y., Ma S. Synthesis and antibacterial e valuation of novel 11,4”-disubstituted azithromycin analogs with greatly improved activity against erythromycin-resistant bacteria. Europ J Med Chem 2013; 59: 209-217.
Review
For citations:
Printsevskaya S.S., Korolev A.M., Isakova E.B., Mirchink E.P., Tevyashova A.N. Hybrid Antibiotics Based on Azithromycin and Glycopeptides: Synthesis and Antibacterial Activity. Antibiot Khimioter = Antibiotics and Chemotherapy. 2016;61(11-12):3-8. (In Russ.)
Views:
569
Email this article 